Myo-Inositol

Helps in the management of polycystic ovary syndrome (PCOS) by helping to restore normal ovarian function. Helps manage the hormonal and metabolic conditions of PCOS by promoting healthy glucose metabolism. Helps in the management of PCOS by reducing oxidative stress. Helps restore ovulation and oocyte quality and normalize menstrual irregularities. Helps reduce serum testosterone levels in women with PCOS. Polycystic ovary syndrome (PCOS) is among the most common endocrine disorders, affecting up to 20% of women of reproductive age. PCOS is associated with elevated male sex hormones, impaired insulin sensitivity, and reproductive system dysfunction, including menstrual irregularities and infertility. Meso-inositol helps restore ovarian function in patients with COPD through its role as a precursor to inositol triphosphate (InsP3), which regulates menstrual cycle hormones and egg maturation. Meso-inositol also promotes the production of inositol phosphoglycans (IPGs), which activate enzymes involved in glucose metabolism. In a clinical trial involving 42 women with COPD, participants were randomly assigned to consume 400 mcg of folic acid alone or in combination with 4 g of meso-inositol daily for six to eight weeks. Compared to the placebo group that consumed only folic acid, women in the meso-inositol group experienced a greater number of ovulation cycles (69.5% of women ovulated in the meso-inositol group compared to 21% in the placebo group), lower testosterone levels, and improved insulin sensitivity.